以国外将花粉开发成治疗前列腺炎的药物为例，提出我国中药开发应包括二个阶段：第一阶段是基于临床的治疗，目标的定位，确认其安全性并制定质量标准；第二阶段是进行有效成分的结构测定，深入进行药理、药效的基础研究。遵循这一模式，我国的中药研究可步入国际轨道，中药也易于成为国际公认的药物。 In the case of overseas development of pollen into drugs for the treatment of prostatitis, it is proposed that the development of Chinese medicine should include two phases: the first phase is based on clinical treatment, the positioning of goals, confirming its safety and setting quality standards; the second phase is The structure of active ingredients is measured, and basic research on pharmacology and pharmacodynamics is conducted in depth. Following this model, Chinese medicine research can enter the international track, and Chinese medicine can also easily become an internationally recognized medicine.